DrBrainRx Review
Best for: Neurologist-founded compounded GLP-1 with LegitScript certification and flat-rate pricing
DrBrainRx is a neurologist-founded telehealth clinic led by Dr. Sara Siavoshi (triple board-certified in Neurology, Headache Medicine, and Obesity Medicine) offering compounded semaglutide and tirzepatide injections through USP-certified 503B pharmacies. Flat per-vial monthly pricing covers a 4-week supply at all dose levels, with an additional $25/month provider care fee for dose titration, side-effect management, and clinical messaging. LegitScript certified with 100% online visits and discreet shipping nationwide.
What the monthly price covers
Medication
Included
Provider visits
Included
Shipping
Included
Lab work
Not disclosed
Coaching
Not disclosed
No insurance needed · Vetted by our editors
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more
The Bottom Line
DrBrainRx is a solid telehealth option with balanced features and pricing.
DrBrainRx at a glance
- Type
- GLP-1 telehealth provider
- Medications
- Semaglutide, Tirzepatide
- Starting price
- $199/mo (Verbatim from /products/semaglutide: 'The monthly price is the same for all doses and does not increase as your dose goes up.' Includes 4-week vial (0.25–2.5 mg/week range). Plus $25/month provider care fee for dose titration and support (cancellable anytime).)
- What's included
- Medication · Consult · Shipping
- FDA status
- No FDA warning letter on record
How we scored DrBrainRx
Each dimension is scored algorithmically from DrBrainRx’s real pricing, drugs offered, verification status, and disclosed inclusions — using the same six-dimension framework we apply to every provider.
Value25%
6.6/10At $199/mo, DrBrainRx runs about 17% above the $170 median for GLP-1 providers.
Effectiveness25%
7.9/10DrBrainRx offers both semaglutide and tirzepatide — the two GLP-1 molecules with the strongest published weight-loss trial outcomes.
User Experience15%
7.2/10Online intake and platform experience — consult included in the price; 7 platform features disclosed.
Trust & Safety15%
7.8/10Core details confirmed by our editors; no FDA warning letters on file; dispenses through an accredited compounding pharmacy (last checked 2026-07-04).
Accessibility10%
5.9/10DrBrainRx's exact state footprint isn't published — confirm coverage in your state before signing up.
Support10%
5.7/10DrBrainRx provides standard clinician follow-up; no extended coaching or community program is disclosed.
How we verified this DrBrainRx review
Last checked 2026-07-04- Confirmed current pricing across 2 dose/plan tiers
- Confirmed what the monthly price does and doesn't include
- Checked the FDA warning-letter database for enforcement actions
- Walked the public intake/checkout flow on the provider's site
Pricing, availability, and compliance facts come from the provider's own site and primary regulatory records — see the sources below. Editorial confidence in this data: medium.
GLP-1 medications DrBrainRx offers
Tap any medication to read our plain-English guide — how it works, dosing, side effects, and what the trials found.
Pricing
Verbatim from /products/semaglutide: 'The monthly price is the same for all doses and does not increase as your dose goes up.' Includes 4-week vial (0.25–2.5 mg/week range). Plus $25/month provider care fee for dose titration and support (cancellable anytime).
Verbatim from /products/tirzepatide: flat $299 per 4-week vial at all weekly doses (2.5–15 mg). Plus $25/month provider care fee for dose titration and support (cancellable anytime).
Ready to get started?
Plans and promotions change often — check DrBrainRx's current pricing and active discounts before you decide.
What we like
- Founded and overseen by Dr. Sara Siavoshi — triple board-certified in Neurology, Headache Medicine, and Obesity Medicine
- LegitScript certified with compounded medications from USP-certified 503B pharmacies
- Flat-rate pricing — same monthly cost for all dose levels (dose escalation does not raise price)
- 100% online with rapid approvals (~24-48 hours) and discreet shipping in 3–5 business days
- Side-effect support, dose adjustments, and injection guides included with provider care
Watch-outs
- Separate $25/month provider care fee (compounded track) on top of medication cost
- Compounded medications are not FDA-approved individual drugs
- Labs not required or included — no baseline bloodwork protocol disclosed
- States served not published; no explicit list available
- No dedicated coaching program beyond clinical dose management
Is DrBrainRx worth it? Our verdict
DrBrainRx positions itself around one thing: Neurologist-founded compounded GLP-1 with LegitScript certification and flat-rate pricing. It runs $199/month — a premium to the category, so the extras need to justify it.
On top of the prescription itself, DrBrainRx points to LegitScript certified, Neurologist-founded, and 503B pharmacy.
How much DrBrainRx actually costs
- Compounded semaglutide — $199/month
- Compounded tirzepatide — $299/month
For context, the typical ongoing price across the GLP-1 providers we track is around $170/month, so DrBrainRx's standing rate sits at the premium end.
For a direct comparison, RNK Health runs semaglutide and tirzepatide from $197/month — worth pricing against DrBrainRx before you commit.
Medications: what DrBrainRx prescribes
DrBrainRx prescribes semaglutide (the active drug in Wegovy and Ozempic) and tirzepatide (the active drug in Zepbound and Mounjaro) — the pair backed by the largest published weight-loss trials. The medication is compounded at a licensed pharmacy rather than sold as a brand pen, which is what keeps the price down. The trade-off is the one every compounded provider shares: compounded drugs aren't FDA-approved as finished products.
Who DrBrainRx is best for — and who should skip it
A good fit if you…
- want a straightforward telehealth GLP-1 program.
Look elsewhere if you…
- want the lowest total cost over 6–12 months — a flat-rate provider like bmiMD will likely beat the ongoing price.
- specifically want an FDA-approved brand-name pen.
- need to bill insurance — like most of this market, it's cash-pay.
Trust, safety, and medical oversight
DrBrainRx dispenses through an accredited compounding pharmacy. We found no FDA warning letters on file for the provider. As with any compounded program, the most important step you can take is confirming which licensed pharmacy fills your prescription and what's in the formulation — we explain how in our scoring methodology.
Bottom line
DrBrainRx costs more than the budget end of the market, so it makes the most sense if its specific extras matter to you. If they don't, you can likely get the same medication for less elsewhere. If you're comparison-shopping, Breeze Meds is one of the closest alternatives we track — worth a look before deciding.
Ready to start with DrBrainRx?
Starting at $199/month. See current pricing and start your free consultation.
Alternatives to DrBrainRx
Enhance MD
Best for: lab-monitored compounded GLP-1 with mandatory video visit
Editorial score · methodology
Editorial score · methodology
Editorial score · methodology
Frequently Asked Questions
Key terms, explained
New to GLP-1s? Tap any term for a quick, plain-English definition.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Prior authorization (PA) · Insurance and regulatory
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Sources
The primary regulatory filings and peer-reviewed studies cited throughout this DrBrainRx review:
Sources & methodology — as of July 2026
- 1.Weight Loss Rankings — GLP-1 Pricing Index 2026 (our independent dataset)— WeightLossRankings.org.
- 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
- 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
- 4.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
- 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
- 6.STEP 1 Trial — Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding JPH et al.)— New England Journal of Medicine.PMID: 33567185.
- 7.FDA — Wegovy (semaglutide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 8.FDA — Ozempic (semaglutide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 9.SURMOUNT-1 Trial — Tirzepatide Once Weekly for the Treatment of Obesity (Jastreboff AM et al.)— New England Journal of Medicine.PMID: 35658024.
- 10.FDA — Zepbound (tirzepatide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 11.FDA — Mounjaro (tirzepatide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 12.SURMOUNT-5 Trial — Tirzepatide vs. Semaglutide Head-to-Head in Obesity (Garvey WT et al.)— New England Journal of Medicine.PMID: 40334173.
Ready to start with DrBrainRx?
Starting at $199/month. See current pricing and start your free consultation.